210 related articles for article (PubMed ID: 21928248)
21. Updated assessment of the association of the XRCC1 Arg399Gln polymorphism with lung cancer risk in the Chinese population.
Yang HY; Yang SY; Shao FY; Wang HY; Wang YD
Asian Pac J Cancer Prev; 2015; 16(2):495-500. PubMed ID: 25684477
[TBL] [Abstract][Full Text] [Related]
22. XRCC1 polymorphisms are associated with cervical cancer risk and response to chemotherapy: a systematic review and meta-analysis.
Shuai HL; Luo X; Yan RL; Li J; Chen DL
Asian Pac J Cancer Prev; 2012; 13(12):6423-7. PubMed ID: 23464469
[TBL] [Abstract][Full Text] [Related]
23. The association of XRCC1 gene single nucleotide polymorphisms with response to neoadjuvant chemotherapy in locally advanced cervical carcinoma.
Cheng XD; Lu WG; Ye F; Wan XY; Xie X
J Exp Clin Cancer Res; 2009 Jun; 28(1):91. PubMed ID: 19563645
[TBL] [Abstract][Full Text] [Related]
24. The XRCC1 399Gln polymorphism and the frequency of p53 mutations in Taiwanese oral squamous cell carcinomas.
Hsieh LL; Chien HT; Chen IH; Liao CT; Wang HM; Jung SM; Wang PF; Chang JT; Chen MC; Cheng AJ
Cancer Epidemiol Biomarkers Prev; 2003 May; 12(5):439-43. PubMed ID: 12750239
[TBL] [Abstract][Full Text] [Related]
25. A Strong Relationship Between Oral Squamous Cell Carcinoma and DNA Repair Genes.
Avci H; Ergen A; Bireller ES; Ertugrul B; Cakmakoglu B
Biochem Genet; 2017 Dec; 55(5-6):378-386. PubMed ID: 28639054
[TBL] [Abstract][Full Text] [Related]
26. XRCC1 genetic polymorphism Arg399Gln and hepatocellular carcinoma risk: a meta-analysis.
Liu F; Li B; Wei Y; Yan L; Wen T; Zhao J; Xu M
Liver Int; 2011 Jul; 31(6):802-9. PubMed ID: 21645210
[TBL] [Abstract][Full Text] [Related]
27. XRCC1 Arg399Gln polymorphism and risk for cervical cancer development in Argentine women.
Barbisan G; Pérez LO; Difranza L; Fernández CJ; Ciancio NE; Golijow CD
Eur J Gynaecol Oncol; 2011; 32(3):274-9. PubMed ID: 21797115
[TBL] [Abstract][Full Text] [Related]
28. Effect of Arg399Gln single-nucleotide polymorphism in
Dutta D; Abarna R; Shubham M; Subbiah K; Duraisamy S; Chinnusamy R; Anbalagan M
J Cancer Res Ther; 2020; 16(3):551-558. PubMed ID: 32719266
[TBL] [Abstract][Full Text] [Related]
29. XRCC1 Arg194Trp and Arg399Gln polymorphisms and arsenic methylation capacity are associated with urothelial carcinoma.
Chiang CI; Huang YL; Chen WJ; Shiue HS; Huang CY; Pu YS; Lin YC; Hsueh YM
Toxicol Appl Pharmacol; 2014 Sep; 279(3):373-379. PubMed ID: 25018058
[TBL] [Abstract][Full Text] [Related]
30. XRCC1 Arg399Gln variation and leukemia susceptibility: evidence from 2,647 cases and 5,518 controls.
Huang Y; Xie D; Tang N; Wang J; Zeng X; Zhao P; He L
Tumour Biol; 2014 Jan; 35(1):799-808. PubMed ID: 23990457
[TBL] [Abstract][Full Text] [Related]
31. Genetic polymorphisms in DNA repair genes XRCC1 and 3 are associated with increased risk of breast cancer in Bangladeshi population.
Howlader NR; Rahman MM; Hossain MA; Sultana R; Hossain SM; Mazid MA; Rahman MM
Breast Cancer Res Treat; 2020 Aug; 182(3):739-750. PubMed ID: 32562117
[TBL] [Abstract][Full Text] [Related]
32. Association between the XRCC1 Arg399Gln polymorphism and risk of cervical carcinoma: a meta-analysis.
Liu DY; Liang HC; Xiao XM
Genet Mol Res; 2015 Aug; 14(3):9821-8. PubMed ID: 26345915
[TBL] [Abstract][Full Text] [Related]
33. XRCC1 genetic polymorphism Arg399Gln and gastric cancer risk: A meta-analysis.
Geng J; Zhang YW; Huang GC; Chen LB
World J Gastroenterol; 2008 Nov; 14(43):6733-7. PubMed ID: 19034980
[TBL] [Abstract][Full Text] [Related]
34. Association between Arg399Gln polymorphism of X-ray repair cross-complementing 1 (XRCC1) gene and sporadic endometrial cancer in the Polish population.
Samulak D; Romanowicz-Makowska H; Smolarz B; Kulig A; Sporny S
Eur J Gynaecol Oncol; 2011; 32(5):491-5. PubMed ID: 22053659
[TBL] [Abstract][Full Text] [Related]
35. Genetic polymorphisms of XRCC1, alcohol consumption, and the risk of colorectal cancer in Japan.
Yin G; Morita M; Ohnaka K; Toyomura K; Hamajima N; Mizoue T; Ueki T; Tanaka M; Kakeji Y; Maehara Y; Okamura T; Ikejiri K; Futami K; Yasunami Y; Maekawa T; Takenaka K; Ichimiya H; Terasaka R
J Epidemiol; 2012; 22(1):64-71. PubMed ID: 22186158
[TBL] [Abstract][Full Text] [Related]
36. A population-based case-control study of the Arg399Gln polymorphism in DNA repair gene XRCC1 and risk of breast cancer.
Shu XO; Cai Q; Gao YT; Wen W; Jin F; Zheng W
Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1462-7. PubMed ID: 14693738
[TBL] [Abstract][Full Text] [Related]
37. Association and multiple interaction analysis among five XRCC1 polymorphic variants in modulating lung cancer risk in North Indian population.
Singh A; Singh N; Behera D; Sharma S
DNA Repair (Amst); 2016 Nov; 47():30-41. PubMed ID: 27707541
[TBL] [Abstract][Full Text] [Related]
38. A prospective study of XRCC1 (X-ray cross-complementing group 1) polymorphisms and breast cancer risk.
Patel AV; Calle EE; Pavluck AL; Feigelson HS; Thun MJ; Rodriguez C
Breast Cancer Res; 2005; 7(6):R1168-73. PubMed ID: 16457697
[TBL] [Abstract][Full Text] [Related]
39. Polymorphisms of DNA repair gene XRCC1 and hepatocellular carcinoma risk among East Asians: a meta-analysis.
Li J; Li Z; Feng L; Guo W; Zhang S
Tumour Biol; 2013 Feb; 34(1):261-9. PubMed ID: 23055199
[TBL] [Abstract][Full Text] [Related]
40. Polymorphisms of the DNA repair genes XPD (Lys751Gln) and XRCC1 (Arg399Gln and Arg194Trp): relationship to breast cancer risk and familial predisposition to breast cancer.
Brewster AM; Jorgensen TJ; Ruczinski I; Huang HY; Hoffman S; Thuita L; Newschaffer C; Lunn RM; Bell D; Helzlsouer KJ
Breast Cancer Res Treat; 2006 Jan; 95(1):73-80. PubMed ID: 16319991
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]